Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026. Torsten Woehr, incoming CEO of Rentschler Biopharma, commented: “Rentschler Biopharma is r…
Muna Therapeutics, a biotechnology company pioneering novel therapeutics for neurodegenerative diseases, announced a CEO transition. Rita Balice-Gordon, Ph.D., Muna's founding CSO and CEO since 2021, will step down and join the Company's Board of Directors. Michel Detheux, Ph.D., a seasoned biotech entrepreneur and fo…
Sanofi announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1, 2026. He will be a member of Sanofi's Executive Committee, based in Paris, and will report to Chief Executive Officer Belén Garijo. As head of R&D…
Pfizer Inc. announced that Dave Denton, Chief Financial Officer, will step down from his current role and leave the company on August 15 for a professional opportunity outside of the pharmaceutical industry in consumer goods, which he has accepted. The company has named Cecile Guegan, currently Senior Vice President,…
Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad to the position of General Manager of Saudi Arabia and Gulf Countries effective June 1, 2026. In this role, Mayada will lead the affiliate spanning Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain,…
Lonza announced the appointment of Hans Trees as Global Head of Communications, Senior Vice President and member of the Extended Executive Committee. Hans will join Lonza on 1 September 2026 and succeed David Carter, who has led Lonza’s Communications function since 2019. Hans is a seasoned communications executive …
SOPHiA GENETICS, a global leader in Ai-driven precision medicine, confirmed, ahead of its 2026 Annual General Meeting (AGM) scheduled for June 18, 2026, the leadership changes first announced in January 2026. The Board has appointed Ross Muken, currently President, as Chief Executive Officer, effective July 1, 2026, …
Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox platform-based photoimmunotherapy, announced that Hiroshi "Mickey" Mikitani will transition from Chief Executive Officer (CEO) to Executive Chairman of the Board, and President Minami Maeda will become the next CEO, effectiv…
West Pharmaceutical, a global leader in innovative solutions for injectable drug administration, announced that its Board of Directors has appointed Michel Lagarde to be President and Chief Executive Officer (CEO) and a member of the Company's Board of Directors starting August 31, 2026. He succeeds Eric M. Green, who…
LUCENT Biopharma Ltd. has appointed Simon Doyle as CEO with immediate effect. As LUCENT enters its next phase of growth, this leadership change will ensure the continued strength of its culture and reputation, with Doyle providing the leadership required to deliver the three-year growth strategy, while Goodman remai…
Page 3 of 15